FAScinate Therapeutics is a clinical-stage company focused on developing disease-modifying drugs for neurodegenerative diseases such as Parkinson's disease and multiple system atrophy. The company is involved in the development of novel drugs and therapeutics aimed at treating these conditions.
Focus Areas
Notable Investments